banner
Inquiry

Other inhibitors

Cat. No. Product Name Inquiry
X24-09-YM1363 Coelenterazine, Purity ≥98%
X24-09-YM1364 Dp44mT, Purity ≥98%
X24-09-YM1365 PI3Kα inhibitor, Brevianamide F, Purity ≥98%
X24-09-YM1366 Alanosine, Purity ≥98%
X24-09-YM1367 GABOB, Purity ≥98%
X24-09-YM1368 Iloprost, Purity ≥98%
X24-09-YM1370 J147, Purity ≥98%
X24-09-YM1372 Emeramide, Purity ≥98%
X24-09-YM1374 Hexaminolevulinate HCl, Purity ≥98%
X24-09-YM1375 Sugammadex sodium, Purity ≥98%
X24-09-YM1376 4-Aminobenzoic acid, Purity ≥98%
X24-09-YM1377 4-Aminoantipyrine, Purity ≥98%
X24-09-YM1378 Iopamidol, Purity ≥98%
X24-09-YM1380 Citric acid trilithium salt tetrahydrate, Purity ≥98%
X24-09-YM1381 RETF-4NA, Purity ≥98%
X24-09-YM1382 PKA inhibitor, KT 5823, Purity ≥98%
X24-09-YM1383 Rp-8-Br-PET-cGMPS, Purity ≥98%
X24-09-YM1384 Madrasin, Purity ≥98%
X24-09-YM1385 Butamben, Purity ≥98%
X24-09-YM1386 Propiolamide, Purity ≥98%
X24-09-YM1387 6-Carboxyfluorescein, Purity ≥98%
X24-09-YM1388 HA15, Purity ≥98%
X24-09-YM1390 Molsidomine, Purity ≥98%
X24-09-YM1391 D panthenol, Purity ≥98%
X24-09-YM1392 Oxybenzone, Purity ≥98%
X24-09-YM1393 Protirelin, Purity ≥98%
X24-09-YM1395 Dehydrocholic acid, Purity ≥98%
X24-09-YM1396 RS-1, Purity ≥98%
X24-09-YM1397 Sulisobenzone, Purity ≥98%
X24-09-YM1398 Glutathione, Purity ≥98%
X24-09-YM1400 SCH00013, Purity ≥98%
X24-09-YM1401 3,3'-Diindolylmethane, Purity ≥98%
X24-09-YM1402 HMN-176, Purity ≥98%
X24-09-YM1403 HTHQ, Purity ≥98%
X24-09-YM1404 VULM 1457, Purity ≥98%
X24-09-YM1405 CI 976, Purity ≥98%
X24-09-YM1407 4-Aminohippuric acid, Purity ≥98%
X24-09-YM1408 6-Acetamidohexanoic acid, Purity ≥98%
X24-09-YM1409 Aceglutamide, Purity ≥98%
X24-09-YM1410 Acesulfame potassium, Purity ≥98%

About Us

CD BioGlyco is a leading biotechnology company specializing in glycobiology. We deliver high-quality products and services to support cutting-edge research worldwide.

Contact Us

  • For research and manufacturing partners only. Not intended for (direct) human or veterinary use.
Copyright © CD BioGlyco. All rights reserved.
0